asthma
NIH to Trial Dupilumab for Asthma
[ad_1]
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attack...
Children’s asthma rates linked with neighborhood characteristics, race, ethnicity | News
[ad_1]
June 9, 2022 – Children living in neighborhoods with higher population densities, greater proportions of lower-income households, and grea...
NIAID trial to test asthma drug in disadvantaged urban children
[ad_1]
…according to the National Institute of Allergy and Infectious Diseases.
Black and Hispanic children who live in these environments ar...
NIH Launches Phase 2 Trial of Biologic in Urban Youth With Type 2 Allergic Asthma
[ad_1]
Little data exist on the effectiveness of dupilumab in Black and Hispanic children, even though severe asthma disproportionately affects th...
NIH launches trial of monoclonal antibody to treat asthma in urban youth
[ad_1]
Study also will examine relationship of airway gene network activity to health outcomes.
Dupilumab is approved by the U.S. Food and Drug A...
Asthma rates higher among Black and Hispanic kids regardless of neighborhood income, density
[ad_1]
May 25, 2022 9:27 AM
Posted: May 25, 2022 9:27 AM
Updated: May 25, 2022 9:28 AM
MADISON (WKBT) – A new study shows rates of child...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
